| Pfizer AG - BeneFIX 250, Trockensubstanz zur i.v. Injektion |
| 54510 | | 01 | | BeneFIX 250 | | Trockensubstanz zur i.v. Injektion | | B02BD04 | | Coagulation Factor Ix | | 26.02.1998 | | |
|
| Composition |
| Praeparatio cryodesiccata: nonacogum alfa 250 U.I., histidinum, glycinum, saccharum, polysorbatum 80, pro vitro.
Solvens: natrii chloridum, aqua ad iniectabile 5 ml. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Trockensubstanz zur i.v. Injektion | | | | | | | | Active Agent | Dose |
|---|
| Nonacog Alfa | 250 UI |
| | BAG: Active Agent | Dose |
|---|
| Nonacog Alfa | 250 UI |
| | | | Inactive agents |
|---|
| Glycin | | Histidine | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 041 | Set(s) | 178.71 | 224.40 | B | SL | Yes |
|
